Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.

about

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.

Item

http://www.wikidata.org/entity/Q52638921

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@en

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@nl

type

Item

label

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@en

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@nl

prefLabel

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@en

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@nl

P1476

Efatutazone and T0901317 exert ...... ant lung adenocarcinoma cells.

@en

P2093

Haixia Cao

http://www.w3.org/2001/XMLSchema#string

Huizi Li

http://www.w3.org/2001/XMLSchema#string

Jianzhong Wu

http://www.w3.org/2001/XMLSchema#string

Jie Ni

http://www.w3.org/2001/XMLSchema#string

Lei-Lei Zhou

http://www.w3.org/2001/XMLSchema#string

Li Ding

http://www.w3.org/2001/XMLSchema#string

Rong Ma

http://www.w3.org/2001/XMLSchema#string

Siwen Liu

http://www.w3.org/2001/XMLSchema#string

Xia Zhao

http://www.w3.org/2001/XMLSchema#string

Xue-Qin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Cancer statistics, 2016

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

Screening for epidermal growth factor receptor mutations in lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.

Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.

A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

P304

1955-1966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1440

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ji-Feng Feng

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29573196

http://www.w3.org/2001/XMLSchema#string

P932

5943475

http://www.w3.org/2001/XMLSchema#string